The PNPLA3 gene has been identified as a genetic determinant of NAFLD, and lean individuals are more susceptible to the effects of PNPLA3 gene polymorphisms, increasing their likelihood of carrying risk alleles compared to overweight and obese individuals [42–44]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.